EUVIMEDOpdag EUVIMED
Open access

New 1,3‐Oxazole and 1,2,4‐Oxadiazole Derivatives as Novel Agents Against Human Rhinovirus and Cytomegalovirus

Yelyzaveta Yu Rybina, Maryna V Kachaeva iD, Agnieszka B Olejniczak iD, Marta Denel-Bobrowska iD, Victor V Zhirnov iD, Ivan V Semenyuta iD, Stepan G Pilyo iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70491 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Yelyzaveta Yu Rybina and 6 co-authors. Institution: Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, Nation…. Major MEDLINE topics: Oxadiazoles, Antiviral Agents, Rhinovirus, Oxazoles. 52 references. The full text is freely available in PubMed Central. Funded by: Ministry of Science and Higher Education, National Research Foundation of Ukraine.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A library of 16 new five‐functionalized derivatives of 2‐undecyl‐ and 1,2,4‐oxadiazole‐containing 2‐aryl‐4‐cyano‐1,3‐oxazoles was synthesized using α ‐acylamino‐ β , β ‐dichloroacrylonitriles as key building blocks, enabling efficient formation of diverse 1,3‐oxazole, oxadiazole–oxazole, and sulfonamide–oxazole systems. The antiviral potential was evaluated in vitro against rhinovirus 8 (HRV8), cytomegalovirus (HCMV), parainfluenza virus type 3 (HPIV‐3), and zoonotic encephalomyocarditis virus (EMCV). Screening revealed distinct activity profiles: none of the compounds inhibited EMCV or HPIV‐3, while several demonstrated pronounced efficacy against HRV8 and HCMV. In concentration‐dependent assays, compounds 1, 7, 10, 13 , and 14 exhibited potent anti‐HCMV effects (IC 50 = 0.42–4.67 µM). Compound 7 showed remarkable selectivity (SI = 465), outperforming ganciclovir (GCV, SI = 326). Against HRV8, compound 2 was the most active (IC 50 = 1.67 µM, SI = 11), whereas compound 13 displayed weak activity (IC 50 = 21.0 µM, SI = 1). All molecules met drug‐likeness criteria with favorable ADMET‐predicted pharmacokinetic parameters. Molecular docking suggested that derivatives 7, 10, 13 , and 14 may target viral DNA polymerase, with binding energies from –8.8 to –9.7 kcal mol −1 . These findings demonstrate that 1,3‐oxazoles represent a promising chemotype for new antiviral candidates active against HCMV and HRV8.

Subjects

MeSH terms (MEDLINE)

OxadiazolesAntiviral AgentsRhinovirusOxazolesCytomegalovirusHumansStructure-Activity RelationshipMolecular Docking SimulationMicrobial Sensitivity TestsDose-Response Relationship, DrugMolecular Structure

Author keywords

1,2,4‐oxadiazoles4‐cyano‐1,3‐oxazolesADMET and molecular docking analysiscytomegalovirusrhinovirus

Substances

OxadiazolesAntiviral AgentsOxazoles1,2,4-oxadiazole

Authors and institutions

  • Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Science of Ukraine, Kyiv, Ukraine.
  • Screening Laboratory, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.

ORCID profiles: Maryna V Kachaeva, Agnieszka B Olejniczak, Marta Denel-Bobrowska, Victor V Zhirnov, Ivan V Semenyuta, Stepan G Pilyo

Funding

  • Ministry of Science and Higher Education
  • National Research Foundation of Ukraine

Cite

APA

Rybina, Y. Y., Kachaeva, M. V., Olejniczak, A. B., Denel-Bobrowska, M., Zhirnov, V. V., Semenyuta, I. V., & Pilyo, S. G. (2026). New 1,3‐Oxazole and 1,2,4‐Oxadiazole Derivatives as Novel Agents Against Human Rhinovirus and Cytomegalovirus. ChemMedChem. https://doi.org/10.1002/cmdc.70491

Vancouver

Rybina YY, Kachaeva MV, Olejniczak AB, Denel-Bobrowska M, Zhirnov VV, Semenyuta IV, et al. New 1,3‐Oxazole and 1,2,4‐Oxadiazole Derivatives as Novel Agents Against Human Rhinovirus and Cytomegalovirus. ChemMedChem. 2026. doi:10.1002/cmdc.70491

BibTeX
@article{Rybina2026,
  author = {Rybina, Yelyzaveta Yu and Kachaeva, Maryna V and Olejniczak, Agnieszka B and Denel-Bobrowska, Marta and Zhirnov, Victor V and Semenyuta, Ivan V and Pilyo, Stepan G},
  title = {New 1,3‐Oxazole and 1,2,4‐Oxadiazole Derivatives as Novel Agents Against Human Rhinovirus and Cytomegalovirus},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70491}
}
Start for free →